|Dr. Sean Michael Hall||MD, CEO & Director||574.11k||N/A||1970|
|Mr. Kerem Kaya||CFO, COO & Company Sec.||292.83k||N/A||1973|
|Dr. David A. Rutolo (USA), J.D., Ph.D.||Director of Science||187.44k||N/A||N/A|
|Mr. Ian Curtinsmith||Chief Information Officer||234.42k||N/A||N/A|
Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.
Medlab Clinical Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.